<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00963560</url>
  </required_header>
  <id_info>
    <org_study_id>M09-008</org_study_id>
    <nct_id>NCT00963560</nct_id>
  </id_info>
  <brief_title>Presbyopia-Correcting Intraocular Lenses (IOLs)</brief_title>
  <official_title>A Randomized, Subject-masked Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting IOLs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prospectively evaluate postoperative visual and refractive
      parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting
      Intraocular Lenses (IOLs).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>6 Months after surgery</time_frame>
    <description>Best corrected vision was tested at 4 meters (m), 60 centimeters (cm), 40cm and at preferred distance (distance chosen by each subject) with a standard ETDRS chart for distance and a hand held chart for near. Scores were calculated using logMAR values. LogMAR is the &quot;logarithm of the minimum angle of resolution&quot;. A lower logMAR value indicates better visual acuity. Preferred distance for each study group was as follows: ReSTOR +3 = 38.7 +/- 6.8 cm, Crystalens HD = 49.9 +/- 9.8 cm, Crystalens AO = 53.1 +/- 9.8 cm.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>ReSTOR +3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral implantation of ReSTOR +3 Intraocular Lens (IOL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crystalens HD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral implantation of Crystalens HD Intraocular Lens (IOL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crystalens AO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral implantation of Crystalens AO Intraocular Lens (IOL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReSTOR +3</intervention_name>
    <description>Bilateral implantation of the AcrySof ReSTOR Aspheric +3 Model SN6AD1 Intraocular lens (IOL) for the treatment of cataract.</description>
    <arm_group_label>ReSTOR +3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Crystalens HD</intervention_name>
    <description>Bilateral implantation of the Crystalens HD intraocular lens (IOL) for the treatment of cataract.</description>
    <arm_group_label>Crystalens HD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Crystalens AO</intervention_name>
    <description>Bilateral implantation of the Crystalens AO intraocular lens (IOL) for the treatment of cataract.</description>
    <arm_group_label>Crystalens AO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed with bilateral cataracts

          -  candidate for presbyopic lens

        Exclusion Criteria:

          -  &gt; 1 Diopter preoperative astigmatism by Keratometry readings

          -  pre-existing conditions that could skew the results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Contact Alcon Call Center For Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2009</study_first_submitted>
  <study_first_submitted_qc>August 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2009</study_first_posted>
  <results_first_submitted>July 13, 2011</results_first_submitted>
  <results_first_submitted_qc>July 13, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 9, 2011</results_first_posted>
  <last_update_submitted>July 13, 2011</last_update_submitted>
  <last_update_submitted_qc>July 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Diane Houtman, Director - Global Scientific Market Affairs Dept</name_title>
    <organization>Alcon Laboratories, Inc.</organization>
  </responsible_party>
  <keyword>ReSTOR +3</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Bilateral diagnosis of cataracts of subjects &gt;21 years of age.</recruitment_details>
      <pre_assignment_details>During the preoperative exam, subjects were examined to ensure they met the inclusion/exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ReSTOR +3</title>
          <description>Bilateral implantation of ReSTOR +3 Intraocular Lens (IOL)</description>
        </group>
        <group group_id="P2">
          <title>Crystalens HD</title>
          <description>Bilateral implantation of Crystalens HD Intraocular Lens (IOL)</description>
        </group>
        <group group_id="P3">
          <title>Crystalens AO</title>
          <description>Bilateral implantation of Crystalens AO Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="41"/>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ReSTOR +3</title>
          <description>Bilateral implantation of ReSTOR +3 Intraocular Lens (IOL)</description>
        </group>
        <group group_id="B2">
          <title>Crystalens HD</title>
          <description>Bilateral implantation of Crystalens HD Intraocular Lens (IOL)</description>
        </group>
        <group group_id="B3">
          <title>Crystalens AO</title>
          <description>Bilateral implantation of Crystalens AO Intraocular Lens (IOL)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="47"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="41"/>
            <count group_id="B4" value="132"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.4" spread="9.4" lower_limit="41" upper_limit="81"/>
                    <measurement group_id="B2" value="64" spread="7.8" lower_limit="50" upper_limit="79"/>
                    <measurement group_id="B3" value="65.3" spread="7.5" lower_limit="50" upper_limit="81"/>
                    <measurement group_id="B4" value="64.23" spread="8.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Best Corrected Visual Acuity</title>
        <description>Best corrected vision was tested at 4 meters (m), 60 centimeters (cm), 40cm and at preferred distance (distance chosen by each subject) with a standard ETDRS chart for distance and a hand held chart for near. Scores were calculated using logMAR values. LogMAR is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity. Preferred distance for each study group was as follows: ReSTOR +3 = 38.7 +/- 6.8 cm, Crystalens HD = 49.9 +/- 9.8 cm, Crystalens AO = 53.1 +/- 9.8 cm.</description>
        <time_frame>6 Months after surgery</time_frame>
        <population>2 ReSTOR +3 subjects and 1 Crystalens HD subject missed their final visits and were not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>ReSTOR +3</title>
            <description>Bilateral implantation of ReSTOR +3 Intraocular Lens (IOL)</description>
          </group>
          <group group_id="O2">
            <title>Crystalens HD</title>
            <description>Bilateral implantation of Crystalens HD Intraocular Lens (IOL)</description>
          </group>
          <group group_id="O3">
            <title>Crystalens AO</title>
            <description>Bilateral implantation of Crystalens AO Intraocular Lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Best Corrected Visual Acuity</title>
          <description>Best corrected vision was tested at 4 meters (m), 60 centimeters (cm), 40cm and at preferred distance (distance chosen by each subject) with a standard ETDRS chart for distance and a hand held chart for near. Scores were calculated using logMAR values. LogMAR is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity. Preferred distance for each study group was as follows: ReSTOR +3 = 38.7 +/- 6.8 cm, Crystalens HD = 49.9 +/- 9.8 cm, Crystalens AO = 53.1 +/- 9.8 cm.</description>
          <population>2 ReSTOR +3 subjects and 1 Crystalens HD subject missed their final visits and were not included in this analysis.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4m (far) Distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.075" spread="0.100"/>
                    <measurement group_id="O2" value="-0.080" spread="0.103"/>
                    <measurement group_id="O3" value="-0.081" spread="0.110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60cm (intermediate) Distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.227" spread="0.119"/>
                    <measurement group_id="O2" value="0.176" spread="0.139"/>
                    <measurement group_id="O3" value="0.200" spread="0.154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40 cm (near) Distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.057" spread="0.086"/>
                    <measurement group_id="O2" value="0.364" spread="0.183"/>
                    <measurement group_id="O3" value="0.420" spread="0.188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preferred Distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.055" spread="0.121"/>
                    <measurement group_id="O2" value="0.223" spread="0.146"/>
                    <measurement group_id="O3" value="0.222" spread="0.138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Day of surgery until visit 6 months following surgery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ReSTOR +3</title>
          <description>Bilateral implantation of ReSTOR +3 Intraocular Lens (IOL)</description>
        </group>
        <group group_id="E2">
          <title>Crystalens HD</title>
          <description>Bilateral implantation of Crystalens HD Intraocular Lens (IOL)</description>
        </group>
        <group group_id="E3">
          <title>Crystalens AO</title>
          <description>Bilateral implantation of Crystalens AO Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>All data and discoveries arising out of the study, patentable or nonpatentable, shall be the sole property of Alcon Laboratories, Inc. Alcon reserves the right of prior review of any publication or presentation of information related to the study. Alcon may use these data now and in the future for presentation or publication at Alcon’s discretion or for submission to government regulatory agencies.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888-451-3937; 817-568-6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

